DCO-Q3 2014 10-Q
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 _________________________________________________________
FORM 10-Q
 _________________________________________________________
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 27, 2014
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File Number 1-8174
 _________________________________________________________
DUCOMMUN INCORPORATED
(Exact name of registrant as specified in its charter)
 _________________________________________________________
Delaware
 
95-0693330
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
23301 Wilmington Avenue, Carson, California
 
90745-6209
(Address of principal executive offices)
 
(Zip code)
Registrant’s telephone number, including area code: (310) 513-7200

(Former name, former address and former fiscal year, if changed since last report)
 _________________________________________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x  No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
 
¨
Accelerated filer
 
x
 
 
 
 
Non-accelerated filer
 
¨
Smaller reporting company
 
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x
As of October 13, 2014, the registrant had 10,945,806 shares of common stock outstanding.


Table of Contents

DUCOMMUN INCORPORATED AND SUBSIDIARIES
 
 
 
Page
PART I. FINANCIAL INFORMATION
 
 
 
 
 
Item 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 2.
 
 
 
 
 
Item 3.
 
 
 
 
 
Item 4.
 
PART II. OTHER INFORMATION
 
 
 
 
 
Item 1.
 
 
 
 
 
Item 1A.
 
 
 
 
 
Item 4.
 
 
 
 
 
Item 6.
 
 
 


2

Table of Contents

PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
Ducommun Incorporated and Subsidiaries
Condensed Consolidated Balance Sheets
(Unaudited)
(In thousands, except share and per share data)

 
 
September 27,
 
December 31,
 
 
2014
 
2013
Assets
 
 
 
 
Current Assets
 
 
 
 
Cash and cash equivalents
 
$
40,852

 
$
48,814

Accounts receivable, net of allowance for doubtful accounts of $275 and $489 at September 27, 2014 and December 31, 2013, respectively
 
104,396

 
91,909

Inventories
 
145,468

 
140,507

Production cost of contracts
 
10,375

 
11,599

Deferred income taxes
 
13,664

 
10,850

Other current assets
 
20,444

 
27,085

Total Current Assets
 
335,199

 
330,764

Property and Equipment, Net
 
93,181

 
96,090

Goodwill
 
161,940

 
161,940

Intangibles, Net
 
157,694

 
165,465

Other Assets
 
7,657

 
9,940

Total Assets
 
$
755,671

 
$
764,199

Liabilities and Shareholders’ Equity
 
 
 
 
Current Liabilities
 
 
 
 
Current portion of long-term debt
 
$
26

 
$
25

Accounts payable
 
55,083

 
58,111

Accrued liabilities
 
42,916

 
45,453

Total Current Liabilities
 
98,025

 
103,589

Long-Term Debt, Less Current Portion
 
310,157

 
332,677

Deferred Income Taxes
 
73,078

 
68,489

Other Long-Term Liabilities
 
16,858

 
19,750

Total Liabilities
 
498,118

 
524,505

Commitments and Contingencies (Notes 8, 10)
 

 

Subsequent Event (Note 10)
 

 

Shareholders’ Equity
 
 
 
 
Common stock - $0.01 par value; 35,000,000 shares authorized; 10,945,806 and 10,960,054 issued at September 27, 2014 and December 31, 2013, respectively
 
109

 
110

Treasury stock, at cost; zero and 143,300 shares at September 27, 2014 and December 31, 2013, respectively
 

 
(1,924
)
Additional paid-in capital
 
72,563

 
70,542

Retained earnings
 
188,551

 
174,828

Accumulated other comprehensive loss
 
(3,670
)
 
(3,862
)
Total Shareholders’ Equity
 
257,553

 
239,694

Total Liabilities and Shareholders’ Equity
 
$
755,671

 
$
764,199

See accompanying notes to condensed consolidated financial statements.

3

Table of Contents

Ducommun Incorporated and Subsidiaries
Condensed Consolidated Income Statements
(Unaudited)
(In thousands, except per share amounts)

 
 
Three Months Ended
 
Nine Months Ended
 
 
September 27,
2014
 
September 28,
2013
 
September 27,
2014
 
September 28,
2013
Net Revenues
 
$
188,164

 
$
181,288

 
$
554,433

 
$
548,675

Cost of Sales
 
154,770

 
148,984

 
448,526

 
446,202

Gross Profit
 
33,394

 
32,304

 
105,907

 
102,473

Selling, General and Administrative Expenses
 
23,050

 
20,351

 
65,005

 
65,175

Operating Income
 
10,344

 
11,953

 
40,902

 
37,298

Interest Expense
 
(6,975
)
 
(7,403
)
 
(21,094
)
 
(22,668
)
Other Income
 
1,600

 

 
1,600

 

Income Before Taxes
 
4,969

 
4,550

 
21,408

 
14,630

Income Tax Expense (Benefit)
 
2,347

 
(86
)
 
7,685

 
783

Net Income
 
$
2,622

 
$
4,636

 
$
13,723

 
$
13,847

Earnings Per Share
 
 
 
 
 
 
 
 
Basic earnings per share
 
$
0.24

 
$
0.43

 
$
1.26

 
$
1.30

Diluted earnings per share
 
$
0.24

 
$
0.42

 
$
1.23

 
$
1.28

Weighted-Average Number of Common Shares Outstanding
 
 
 
 
 
 
 
 
Basic
 
10,921

 
10,722

 
10,902

 
10,657

Diluted
 
11,150

 
10,917

 
11,202

 
10,785

See accompanying notes to condensed consolidated financial statements.

4

Table of Contents

Ducommun Incorporated and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
(In thousands)
 
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 27,
2014
 
September 28,
2013
 
September 27,
2014
 
September 28,
2013
Net Income
 
$
2,622

 
$
4,636

 
$
13,723

 
$
13,847

Other Comprehensive Loss
 
 
 
 
 
 
 
 
Amortization of actuarial loss and prior service costs, net of tax benefit of approximately $40 and $102 for the three months ended September 27, 2014 and September 28, 2013, respectively, and approximately $124 and $306 for the nine months ended September 27, 2014 and September 28, 2013, respectively
 
(66
)
 
(172
)
 
(192
)
 
(516
)
Other Comprehensive Loss
 
(66
)
 
(172
)
 
(192
)
 
(516
)
Comprehensive Income
 
$
2,556

 
$
4,464

 
$
13,531

 
$
13,331

See accompanying notes to condensed consolidated financial statements.

5

Table of Contents

Ducommun Incorporated and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(In thousands)
 
 
 
Nine Months Ended
 
 
September 27,
2014
 
September 28,
2013
Cash Flows from Operating Activities
 
 
 
 
Net Income
 
$
13,723

 
$
13,847

Adjustments to Reconcile Net Income to
 
 
 
 
Net Cash Provided by Operating Activities:
 
 
 
 
Depreciation and amortization
 
21,829

 
21,375

Stock-based compensation expense
 
2,520

 
1,711

Deferred income taxes
 
1,775

 
45

Recovery of doubtful accounts
 
(214
)
 
(141
)
Other
 
649

 
1,434

Changes in Assets and Liabilities:
 
 
 
 
Accounts receivable
 
(12,273
)
 
4,804

Inventories
 
(4,961
)
 
(206
)
Production cost of contracts
 
(1,408
)
 
(3,396
)
Other assets
 
7,121

 
(9,033
)
Accounts payable
 
(2,447
)
 
(2,910
)
Accrued and other liabilities
 
(5,400
)
 
(12,819
)
Net Cash Provided by Operating Activities
 
20,914

 
14,711

Cash Flows from Investing Activities
 
 
 
 
Purchases of property and equipment
 
(9,329
)
 
(7,321
)
Proceeds from sale of assets
 
83

 
123

Insurance recoveries related to property and equipment
 
1,600

 

Net Cash Used in Investing Activities
 
(7,646
)
 
(7,198
)
Cash Flows from Financing Activities
 
 
 
 
Repayment of term loan and other debt
 
(22,519
)
 
(22,518
)
Debt issue cost paid
 

 
(181
)
Net proceeds from issuance of common stock under stock plans
 
1,289

 
1,246

Net Cash Used in Financing Activities
 
(21,230
)
 
(21,453
)
Net Decrease in Cash and Cash Equivalents
 
(7,962
)
 
(13,940
)
Cash and Cash Equivalents at Beginning of Period
 
48,814

 
46,537

Cash and Cash Equivalents at End of Period
 
$
40,852

 
$
32,597

Supplemental Disclosures of Cash Flow Information
 
 
 
 
Interest paid
 
$
24,090

 
$
25,640

Taxes paid
 
$
3,410

 
$
6,542

Non-cash activities:
 
 
 
 
     Purchases of property and equipment not paid
 
$
418

 
$

See accompanying notes to condensed consolidated financial statements.

6

Table of Contents

Ducommun Incorporated and Subsidiaries
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1. Summary of Significant Accounting Policies
Basis of Presentation
The unaudited condensed consolidated financial statements include the accounts of Ducommun Incorporated and its subsidiaries (“Ducommun,” the “Company,” “we,” “us” or “our”), after eliminating intercompany balances and transactions. The December 31, 2013 condensed consolidated balance sheet data was derived from audited financial statements, but does not contain all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”).
Our significant accounting policies were described in Part IV, Item 15(a)(1), “Note 1. Summary of Significant Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, 2013. We followed the same accounting policies for interim reporting. The financial information included in this Quarterly Report on Form 10-Q should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2013.
In the opinion of management, all adjustments, consisting of recurring accruals, have been made that are necessary to fairly state our condensed consolidated financial position, statements of income, comprehensive income and cash flows in accordance with GAAP for the periods covered by this Quarterly Report on Form 10-Q. The results of operations for the three and nine months ended September 27, 2014 are not necessarily indicative of the results to be expected for the full year ending December 31, 2014.
Our fiscal quarters end on the Saturday closest to the end of March, June and September for the first three fiscal quarters of each year, and ends on December 31 for our fourth fiscal quarter.
Certain reclassifications have been made to prior period amounts to conform to the current year’s presentation.
Use of Estimates
Certain amounts and disclosures included in the unaudited condensed consolidated financial statements required management to make estimates and judgments that affect the amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.
Description of Business
We are a leading global provider of engineering and manufacturing services for high-performance products and high-cost-of failure applications used primarily in the aerospace, defense, industrial, natural resources, medical and other industries. Our subsidiaries are organized into two strategic businesses: Ducommun AeroStructures (“DAS”) and Ducommun LaBarge Technologies (“DLT”), each of which is a reportable operating segment. DAS designs, engineers and manufactures large, complex contoured aerospace structural components and assemblies and supplies composite and metal bonded structures and assemblies. DAS products are used on commercial aircraft, military fixed-wing aircraft and military and commercial rotary-wing aircraft. DLT designs, engineers and manufactures high-reliability products used in worldwide technology-driven markets including aerospace and defense, natural resources, industrial and medical and other end-use markets. DLT’s product offerings range from prototype development to complex assemblies. All reportable operating segments follow the same accounting principles.
Earnings Per Share
Basic earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding in each period. Diluted earnings per share are computed by dividing income available to common shareholders plus income associated with dilutive securities by the weighted-average number of common shares outstanding, plus any potential dilutive shares that could be issued if exercised or converted into common stock in each period.
The net earnings, weighted-average number of common shares outstanding used to compute earnings per share were as follows:
 

7

Table of Contents

 
 
(In thousands, except per share data)
Three Months Ended
 
(In thousands, except per share data)
Nine Months Ended
 
 
September 27,
2014
 
September 28,
2013
 
September 27,
2014
 
September 28,
2013
Net earnings
 
$
2,622

 
$
4,636

 
$
13,723

 
$
13,847

Weighted-average number of common shares outstanding
 
 
 
 
 
 
 
 
Basic weighted-average common shares outstanding
 
10,921

 
10,722

 
10,902

 
10,657

Dilutive potential common shares
 
229

 
195

 
300

 
128

Diluted weighted-average common shares outstanding
 
11,150

 
10,917

 
11,202

 
10,785

Earnings per share
 
 
 
 
 
 
 
 
Basic
 
$
0.24

 
$
0.43

 
$
1.26

 
$
1.30

Diluted
 
$
0.24

 
$
0.42

 
$
1.23

 
$
1.28

Potentially dilutive stock options and stock units to purchase common stock, as shown below, were excluded from the computation of diluted earnings per share because their inclusion would have been anti-dilutive. However, these shares may be potentially dilutive common shares in the future.
 
 
(In thousands)
Three Months Ended
 
(In thousands)
Nine Months Ended
 
 
September 27,
2014
 
September 28,
2013
 
September 27,
2014
 
September 28,
2013
Stock options and stock units
 
229

 
219

 
187

 
612

Cash and Cash Equivalents
Our cash accounts are not reduced for checks written until the checks are presented for payment and paid by our bank. Cash equivalents consist of highly liquid instruments purchased with original maturities of three months or less. These assets are valued at cost, which approximates fair value, which we classify as Level 1. See Fair Value below.
Provision for Estimated Losses on Contracts
Provisions for estimated losses on contracts are recorded during the period in which it is determined that total anticipated contract costs will exceed total anticipated contract revenues. The provisions for estimated losses on contracts require management to make certain estimates and assumptions, including those with respect to the future revenue under a contract and the future cost to complete the contract. Management's estimate of the future cost to complete a contract may include assumptions as to improvements in manufacturing efficiency, reductions in operating and material costs, and our ability to resolve claims and assertions with our customers. If any of these or other assumptions and estimates do not materialize in the future, we may be required to record additional provisions for estimated losses on contracts.
Inventory Valuation
Inventories are stated at the lower of cost or market, cost being determined on a first-in, first-out basis. Market value for raw materials is based on replacement costs, and is based on net realizable value for other inventory classifications. Inventoried costs include raw materials, outside processing, direct labor and allocated overhead, adjusted for any abnormal amounts of idle facility expense, freight, handling costs, and wasted materials (spoilage) incurred. Costs under long-term contracts are accumulated into, and removed from, inventory on the same basis as other contracts. We assess the inventory carrying value and reduce it, if necessary, to its net realizable value based on customer orders on hand, and internal demand forecasts using management’s best estimates given information currently available. We maintain an allowance for potentially excess and obsolete inventories and inventories that are carried at costs that are higher than their estimated net realizable values.
Out of Period Adjustments
During the third quarter of 2013, we determined that approximately $1.1 million of inventory had not been valued correctly at our DLT operating segment for periods originating in 2010 through the second quarter of 2013. The errors were attributed to the following quarters; $0.3 million in Q2 2010, $0.5 million in Q2 2011, $0.1 million in Q4 2012, $0.1 million in Q1 2013 and $0.1 million in Q2 2013. We assessed the materiality of these errors and concluded they were immaterial to currently reported annual amounts and previously reported annual and interim amounts. We corrected the errors in the third quarter of 2013 and recorded a $1.1 million charge for inventory reserves for the DLT operating segment and did not restate our condensed consolidated financial statements for the prior annual or interim periods.

8

Table of Contents

Production Cost of Contracts
Production cost of contracts includes non-recurring production costs, such as design and engineering costs, and tooling and other special-purpose machinery necessary to build parts as specified in a contract. Production costs of contracts are recorded to cost of goods sold using the units of delivery method. We review long-lived assets within production costs of contracts for impairment on an annual basis (in the fourth quarter for us) or when events or changes in circumstances indicate that the carrying value of our long-lived assets may not be recoverable. An impairment charge is recognized when the carrying value of an asset exceeds the projected undiscounted future cash flows expected from its use and disposal.
Fair Value
Assets and liabilities that are measured, recorded or disclosed at fair value on a recurring basis are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1, the highest level, refers to the values determined based on quoted prices in active markets for identical assets. Level 2 refers to fair values estimated using significant observable inputs. Level 3, the lowest level, includes fair values estimated using significant unobservable inputs.
Accumulated Other Comprehensive Loss
Accumulated other comprehensive loss, as reflected in the condensed consolidated balance sheets under the equity section, was comprised of cumulative pension and retirement liability adjustments, net of tax.
Recent Accounting Pronouncements

New Accounting Standards Adopted in 2014

In July 2013, the FASB issued Accounting Standards Update 2013-11, “Income Taxes (Topic 740)” (“ASU 2013-11”), which required the netting of unrecognized tax benefits against a deferred tax asset for a loss or other carryforward that would apply in settlement of the uncertain tax positions. This guidance was effective for fiscal years beginning after December 15, 2013, which is our fiscal year 2014, with early adoption permitted. The adoption of this standard at the beginning of our fiscal year 2014 reduced deferred tax assets by approximately $0.6 million as of September 27, 2014.

In February 2013, the FASB issued ASU 2013-04, “Liabilities (Topic 405)” (“ASU 2013-04”), which provided guidance for the recognition, measurement and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation is fixed at the reporting date, except for obligations addressed within existing guidance in GAAP. The new guidance was effective for us beginning January 1, 2014. Early adoption was permitted. The adoption of this standard at the beginning of our fiscal year 2014 did not have a material impact on our condensed consolidated financial statements.

Recently Issued Accounting Standards

In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”), which defines management’s responsibility to evaluate whether there is substantial doubt about a company’s ability to continue as a going concern. ASU 2014-15 also provide principles and definitions that are intended to reduce diversity in the timing and content of disclosures in the financial statement footnotes. The new guidance is effective for annual periods ending after December 15, 2016, which will be our year ending December 31, 2016, and interim periods beginning after December 15, 2016, which will be our interim period beginning January 1, 2017. Early adoption is permitted. We are evaluating the impact of this standard but currently do not anticipate it will have a significant impact on our condensed consolidated financial statements.

In June 2014, the FASB issued ASU 2014-12, “Compensation - Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide that a Performance Target Could be Achieved after the Requisite Service Period” (“ASU 2014-12”), which requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. Thus, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The new guidance is effective for us beginning January 1, 2016. Early adoption is permitted. We currently do not anticipate the adoption of this standard will have a material impact on our condensed consolidated financial statements.

In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014-09”), which

9

Table of Contents

outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized. It requires entities to exercise judgment when considering the terms of the contract(s) which include (i) identifying the contract(s) with the customer, (ii) identifying the separate performance obligations in the contract, (iii) determining the transaction price, (iv) allocating the transaction price to the separate performance obligations, and (v) recognizing revenue when each performance obligation is satisfied. Thus, it depicts the transfer of promised goods or services to customers in an amount that reflects the consideration an entity expects to receive in exchange for those goods or services. Companies have the option of applying the provisions of ASU 2014-09 either retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying this guidance recognized at the date of initial application. Early adoption is not permitted. The new guidance is effective for us beginning January 1, 2017. We are currently evaluating the method and impact that adopting this new accounting standard will have on our condensed consolidated financial statements.

 
Note 2. Inventories
Inventories consisted of the following:
 
 
(In thousands)
 
 
September 27,
 
December 31,
 
 
2014
 
2013
Raw materials and supplies
 
$
79,150

 
$
75,985

Work in process
 
68,746

 
62,115

Finished goods
 
8,766

 
11,580

 
 
156,662

 
149,680

Less progress payments
 
11,194

 
9,173

Total
 
$
145,468

 
$
140,507

 
Note 3. Goodwill
The carrying amounts of goodwill, by operating segment, were as follows:
 
 
(In thousands)
 
 
Ducommun
AeroStructures
 
Ducommun
LaBarge
Technologies
 
Consolidated
Ducommun
Gross goodwill
 
$
57,243

 
$
184,970

 
$
242,213

Accumulated goodwill impairment
 

 
(80,273
)
 
(80,273
)
Balance at December 31, 2013
 
$
57,243

 
$
104,697

 
$
161,940

Balance at September 27, 2014
 
$
57,243

 
$
104,697

 
$
161,940

 
Note 4. Accrued Liabilities
The components of accrued liabilities were as follows:
 
 
(In thousands)
 
 
September 27,
 
December 31,
 
 
2014
 
2013
Accrued compensation
 
$
22,768

 
$
19,929

Accrued income and sales tax
 
1,446

 
1,451

Customer deposits
 
1,342

 
3,236

Interest payable
 
4,227

 
8,965

Provision for forward loss reserves
 
5,123

 
4,825

Other
 
8,010

 
7,047

Total
 
$
42,916

 
$
45,453



10

Table of Contents

Note 5. Long-Term Debt
Long-term debt and the current period interest rates were as follows:
 
 
(In thousands)
 
 
September 27,
 
December 31,
 
 
2014
 
2013
Senior unsecured notes (fixed 9.75%)
 
$
200,000

 
$
200,000

Senior secured term loan (floating 4.75%)
 
110,125

 
132,625

Other debt (fixed 5.41%)
 
58

 
77

Total Debt
 
310,183

 
332,702

Less current portion
 
26

 
25

Total long-term debt
 
$
310,157

 
$
332,677

Weighted-average interest rate
 
7.97
%
 
7.76
%

We made a voluntary principal prepayment on our senior secured term loan of approximately $7.5 million each quarter for an aggregate total of approximately $22.5 million in both the nine months ended September 27, 2014 and September 28, 2013.
As of September 27, 2014, we had approximately $58.5 million of unused borrowing capacity under the revolving credit facility, after deducting approximately $1.5 million for standby letters of credit.
As of September 27, 2014, we were in compliance with all covenants required by our amended credit agreement. Also as of September 27, 2014, there were no amounts outstanding that would have triggered the leverage covenant under the Amended Credit Agreement. Under the terms of the credit agreement, if, during a given fiscal quarter, (i) the sum of (a) any amounts outstanding under the revolving credit facility plus (b) the amount drawn under any letters of credit exceeds $1.0 million or (ii) the aggregate amount of outstanding letters of credit exceeds $5.0 million, the revolving credit facility will be subject to a maximum total leverage ratio.
The carrying amount of our long-term debt approximated fair value, except for the senior unsecured notes for which the fair value was approximately $215.0 million. Fair value was estimated using Level 2 inputs, based on the terms of the related debt, recent transactions and estimates using interest rates currently available to us for debt with similar terms and remaining maturities.

Note 6. Shareholders’ Equity
We are authorized to issue five million shares of preferred stock. At September 27, 2014 and December 31, 2013, no preferred shares were issued or outstanding.
 
Note 7. Employee Benefit Plans
The components of net periodic pension expense were as follows:
 
 
(In thousands)
 
(In thousands)
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 27,
2014
 
September 28,
2013
 
September 27,
2014
 
September 28,
2013
Service cost
 
$
174

 
$
211

 
$
520

 
$
633

Interest cost
 
320

 
290

 
958

 
870

Expected return on plan assets
 
(351
)
 
(306
)
 
(1,052
)
 
(918
)
Amortization of actuarial losses
 
106

 
274

 
316

 
822

Net periodic pension cost
 
$
249

 
$
469

 
$
742

 
$
1,407

The components of the reclassifications of net actuarial losses from accumulated other comprehensive loss to net income for the three and nine months ended September 27, 2014 were as follows:

11

Table of Contents

 
 
(In thousands)
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 27,
2014
 
September 27,
2014
Amortization of actuarial loss - total before tax (1)
 
$
(106
)
 
$
(316
)
Tax benefit
 
40

 
124

Net of tax
 
$
(66
)
 
$
(192
)

(1)
The amortization expense is included in the computation of periodic pension cost and is a decrease to net income upon reclassification from accumulated other comprehensive loss.

Note 8. Indemnifications
We have made guarantees and indemnities under which we may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions, including revenue transactions in the ordinary course of business. In connection with certain facility leases, we have indemnified our lessors for certain claims arising from the facility or the lease. We indemnify our directors and officers to the maximum extent permitted under the laws of the State of Delaware.
However, we have a directors and officers insurance policy that may reduce our exposure in certain circumstances and may enable us to recover a portion of future amounts that may be payable, if any. The duration of the guarantees and indemnities varies and, in many cases is indefinite but subject to statute of limitations. The majority of guarantees and indemnities do not provide any limitations of the maximum potential future payments we could be obligated to make. Historically, payments related to these guarantees and indemnities have been immaterial. We estimate the fair value of our indemnification obligations as insignificant based on this history and insurance coverage and have, therefore, not recorded any liability for these guarantees and indemnities in the accompanying condensed consolidated balance sheets.
 
Note 9. Income Taxes
We recorded income tax expense of approximately $2.3 million (effective tax rate of 47.2%) for the three months ended September 27, 2014 compared to an income tax benefit of approximately $0.1 million (effective tax benefit rate of 1.9%) for the three months ended September 28, 2013. The effective tax rate for for the three months ended September 27, 2014 did not include a benefit from the federal research and development (“R&D”) tax credit as it expired on December 31, 2013. The three months ended September 28, 2013 included a federal R&D tax credit benefit of approximately $0.7 million. In addition, the effective tax rate for the three months ended September 27, 2014 included a total of approximately $0.9 million additional tax expense as a result of lowering our Qualified Domestic Production Activities Deduction due to lower taxable income as a result of tax returns filed or to be filed.
We recorded income tax expense of approximately $7.7 million (effective tax rate of 35.9%) for the nine months ended September 27, 2014 compared to approximately $0.8 million (effective tax rate of 5.4%) for the nine months ended September 28, 2013. The effective tax rate for for the nine months ended September 27, 2014 did not include a benefit from the federal R&D tax credit as it expired on December 31, 2013. The nine months ended September 28, 2013 included a federal R&D tax credit benefit of approximately $3.7 million. This amount included approximately $2.0 million of 2012 federal research and development tax credits benefit recognized in the nine months ended September 28, 2013 as a result of the American Taxpayer Relief Act of 2012 (the “Act”) passed in January 2013. The Act included an extension of the federal R&D tax credit for amounts paid or incurred during 2012 and 2013.
Our unrecognized tax benefits were approximately $2.6 million both as of September 27, 2014 and December 31, 2013, respectively. Most of these amounts, if recognized, would affect the annual income tax rate. It is reasonably possible that the unrecognized tax benefits could be reduced by approximately $0.4 million in the next twelve months.


12

Table of Contents

Note 10. Contingencies
Ducommun is a defendant in a lawsuit entitled United States of America ex rel Taylor Smith, Jeannine Prewitt and James Ailes v. The Boeing Company and Ducommun Inc., filed in the United States District Court for the District of Kansas (the “District Court”). The lawsuit is a qui tam action brought by three former The Boeing Company (“Boeing”) employees (“Relators”) against Boeing and Ducommun on behalf of the United States of America for violations of the United States False Claims Act. The lawsuit alleges that Ducommun sold unapproved parts to Boeing which were installed by Boeing in aircraft ultimately sold to the United States Government and that Boeing and Ducommun submitted or caused to be submitted false claims for payment relating to 21 aircraft sold by Boeing to the United States Government. The lawsuit seeks damages in an amount equal to three times the amount of damages the United States Government sustained because of the defendants’ actions, plus a civil penalty of $10 thousand for each false claim made on or before September 28, 1999, and $11 thousand for each false claim made on or after September 28, 1999, together with attorneys’ fees and costs. The Relators claim that the United States Government sustained damages of $1.6 billion (the contract purchase price of 21 aircraft) or, alternatively, $851 million (the alleged diminished value and increased maintenance cost of the 21 aircraft). After investigating the allegations, the United States Government has declined to intervene in the lawsuit. Subsequent to the Company’s quarter ended September 27, 2014, on October 8, 2014, the District Court granted summary judgment in favor of Boeing and Ducommun and dismissed the lawsuit. The District Court’s decision remains subject to appeal.
DAS has been directed by California environmental agencies to investigate and take corrective action for groundwater contamination at its facilities located in El Mirage and Monrovia, California. Based on currently available information, Ducommun has established a reserve for its estimated liability for such investigation and corrective action of approximately $1.5 million at September 27, 2014, which is reflected in other long-term liabilities on the condensed consolidated balance sheet.
DAS also faces liability as a potentially responsible party for hazardous waste disposed at landfills located in Casmalia and West Covina, California. DAS and other companies and government entities have entered into consent decrees with respect to these landfills with the United States Environmental Protection Agency and/or California environmental agencies under which certain investigation, remediation and maintenance activities are being performed. Based on currently available information, Ducommun preliminarily estimates that the range of its future liabilities in connection with the landfill located in West Covina, California is between approximately $0.4 million and $3.1 million. Ducommun has established a reserve for its estimated liability, in connection with the West Covina landfill of approximately $0.4 million at September 27, 2014, which is reflected in other long-term liabilities on its condensed consolidated balance sheet. Ducommun’s ultimate liability in connection with these matters will depend upon a number of factors, including changes in existing laws and regulations, the design and cost of construction, operation and maintenance activities, and the allocation of liability among potentially responsible parties.
In the normal course of business, Ducommun and its subsidiaries are defendants in certain other litigation, claims and inquiries, including matters relating to environmental laws. In addition, Ducommun makes various commitments and incurs contingent liabilities. While it is not feasible to predict the outcome of these matters, Ducommun does not presently expect that any sum it may be required to pay in connection with these matters would have a material adverse effect on its condensed consolidated financial position, results of operations or cash flows.
 
Note 11. Business Segment Information
We supply products and services primarily to the aerospace and defense industries. Our subsidiaries are organized into two strategic businesses, DAS and DLT, each of which is a reportable operating segment.

Financial information by reportable operating segment was as follows:

13

Table of Contents

 
 
(In thousands)
Three Months Ended
 
(In thousands)
Nine Months Ended
 
 
September 27,
 
September 28,
 
September 27,
 
September 28,
 
 
2014
 
2013
 
2014
 
2013
Net Revenues
 
 
 
 
 
 
 
 
DAS
 
$
81,357

 
$
77,740

 
$
241,627

 
$
234,437

DLT
 
106,807

 
103,548

 
312,806

 
314,238

Total Net Revenues
 
$
188,164

 
$
181,288

 
$
554,433

 
$
548,675

Segment Operating Income
 
 
 
 
 
 
 
 
DAS
 
$
7,190

 
$
7,633

 
$
27,269

 
$
23,766

DLT
 
8,288

 
7,596

 
26,089

 
26,772

 
 
15,478

 
15,229

 
53,358

 
50,538

Corporate General and Administrative Expenses (1)
 
(5,134
)
 
(3,276
)
 
(12,456
)
 
(13,240
)
Operating Income
 
$
10,344

 
$
11,953

 
$
40,902

 
$
37,298

Depreciation and Amortization Expenses
 
 
 
 
 
 
 
 
DAS
 
$
2,272

 
$
2,621

 
$
8,242

 
$
7,386

DLT
 
4,391

 
4,540

 
13,442

 
13,863

Corporate Administration
 
41

 
41

 
145

 
126

Total Depreciation and Amortization Expenses
 
$
6,704

 
$
7,202

 
$
21,829

 
$
21,375

Capital Expenditures
 
 
 
 
 
 
 
 
DAS
 
$
1,266

 
$
1,159

 
$
3,986

 
$
4,208

DLT
 
1,761

 
866

 
4,736

 
3,046

Corporate Administration
 
1

 
43

 
25

 
67

Total Capital Expenditures
 
$
3,028

 
$
2,068

 
$
8,747

 
$
7,321


(1)
Includes costs not allocated to either the DLT or DAS operating segments.
Segment assets include assets directly identifiable with each segment. Corporate assets include assets not specifically identified with a business segment, including cash. Our segment assets are as follows:
 
 
(In thousands)
 
 
September 27,
2014
 
December 31,
2013
Total Assets
 
 
 
 
DAS
 
$
244,207

 
$
241,502

DLT
 
441,443

 
444,224

Corporate Administration
 
70,021

 
78,473

Total Assets
 
$
755,671

 
$
764,199

Goodwill and Intangibles
 
 
 
 
DAS
 
$
63,926

 
$
65,213

DLT
 
255,708

 
262,192

Total Goodwill and Intangibles
 
$
319,634

 
$
327,405



14

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Overview
Ducommun Incorporated (“Ducommun,” the “Company,” “we,” “us” or “our”) is a leading global provider of engineering and manufacturing services for high-performance products and high-cost-of failure applications used primarily in the aerospace, defense, industrial, natural resources, medical and other industries. Ducommun differentiates itself as a full-service solution-based provider, offering a wide range of value-added products and services in our primary businesses of electronics, structures and integrated solutions. We operate through two primary business units: Ducommun LaBarge Technologies (“DLT”) and Ducommun AeroStructures (“DAS”).
Third quarter 2014 highlights were as follows:
Third quarter revenue was $188.2 million
We reported net income of $2.6 million, or $0.24 per diluted share
EBITDA for the quarter was $18.6 million
We made a voluntary principal prepayment of $7.5 million on our term loan during the quarter
Earnings before interest, taxes, depreciation and amortization (“EBITDA”) was approximately $18.6 million and $19.2 million for the three months ended September 27, 2014 and September 28, 2013, respectively. See “Non-GAAP Financial Measures” below for certain information regarding EBITDA, including reconciliation of EBITDA to net income.
Non-GAAP Financial Measures
When viewed with our financial results prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and accompanying reconciliations, we believe EBITDA provides additional useful information to clarify and enhance the understanding of the factors and trends affecting our past performance and future prospects. We define these measures, explain how they are calculated and provide reconciliations of these measures to the most comparable GAAP measure in the tables below. EBITDA and the related financial ratios, as presented in this Form 10-Q, are supplemental measures of our performance that are not required by, or presented in accordance with, GAAP. They are not a measurement of our financial performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP, or as an alternative to net cash provided by operating activities as measures of our liquidity. The presentation of these measures should not be interpreted to mean that our future results will be unaffected by unusual or nonrecurring items.
We use EBITDA as a non-GAAP operating performance measure internally as complementary financial measures to evaluate the performance and trends of our businesses. We present EBITDA and the related financial ratios, as applicable, because we believe that measures such as these provide useful information with respect to our ability to meet our future debt service, capital expenditures, working capital requirements and overall operating performance.
EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as substitutes for analysis of our results as reported under GAAP. Some of these limitations are:
They do not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;
They do not reflect changes in, or cash requirements for, our working capital needs;
They do not reflect the significant interest expense or the cash requirements necessary to service interest or principal payments on our debt;
Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and EBITDA does not reflect any cash requirements for such replacements;
They are not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;
They do not reflect the impact on earnings of charges resulting from matters unrelated to our ongoing operations; and
Other companies in our industry may calculate EBITDA differently from us, limiting their usefulness as comparative measures.

15

Table of Contents

Because of these limitations, EBITDA and the related financial ratios should not be considered as measures of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You should compensate for these limitations by relying primarily on our GAAP results and using EBITDA as only supplemental information. See our condensed consolidated financial statements contained in this Form 10-Q report.
However, in spite of the above limitations, we believe that EBITDA is useful to an investor in evaluating our results of operations because these measures:
Are widely used by investors to measure a company’s operating performance without regard to items excluded from the calculation of such terms, which can vary substantially from company to company depending upon accounting methods and book value of assets, capital structure and the method by which assets were acquired, among other factors;
Help investors to evaluate and compare the results of our operations from period to period by removing the effect of our capital structure from our operating performance; and
Are used by our management team for various other purposes in presentations to our Board of Directors as a basis for strategic planning and forecasting.
The following financial items have been added back to our net income when calculating EBITDA:
Amortization expense may be useful to investors because it represents the estimated attrition of our acquired customer base and the diminishing value of product rights;
Depreciation may be useful to investors because it generally represents the wear and tear on our property and equipment used in our operations;
Interest expense may be useful to investors for determining current cash flow; and
Income tax expense may be useful to investors because it represents the taxes which may be payable for the period and the change in deferred taxes during the period, and may reduce cash flow available for use in our business.
Reconciliations of net income to EBITDA and the presentation of EBITDA as a percentage of net revenues were as follows:
 
 
(In thousands)
Three Months Ended
 
(In thousands)
Nine Months Ended
 
 
September 27,
 
September 28,
 
September 27,
 
September 28,
 
 
2014
 
2013
 
2014
 
2013
Net income
 
$
2,622

 
$
4,636

 
$
13,723

 
$
13,847

Depreciation and amortization
 
6,704

 
7,202

 
21,829

 
21,375

Interest expense
 
6,975

 
7,403

 
21,094

 
22,668

Income tax expense
 
2,347

 
(86
)
 
7,685

 
783

EBITDA
 
$
18,648

 
$
19,155

 
$
64,331

 
$
58,673

% of net revenues
 
9.9
%
 
10.6
%
 
11.6
%
 
10.7
%
 
EBITDA decreased in the three months ended September 27, 2014 compared to the three months ended September 28, 2013, primarily due to decreases in net income, depreciation and amortization expense, and interest expense, partially offset by higher income tax expense.
EBITDA increased in the nine months ended September 27, 2014 compared to the nine months ended September 28, 2013, primarily due to higher income tax expense.



16

Table of Contents

Results of Operations
Third Quarter of 2014 Compared to Third Quarter of 2013
The following table sets forth net revenues, selected financial data, the effective tax rate and diluted earnings per share:

 
 
(in thousands, except per share data)
Three Months Ended
 
(in thousands, except per share data)
Nine Months Ended
 
 
September 27,
2014
 
%
of Net  Revenues
 
September 28,
2013
 
%
of Net  Revenues
 
September 27, 2014
 
%
of Net  Revenues
 
September 28, 2013
 
%
of Net  Revenues
Net Revenues
 
$
188,164

 
100.0
 %
 
$
181,288

 
100.0
 %
 
$
554,433

 
100.0
 %
 
$
548,675

 
100.0
 %
Cost of Sales
 
154,770

 
82.3
 %
 
148,984

 
82.2
 %
 
448,526

 
80.9
 %
 
446,202

 
81.3
 %
Gross Profit
 
33,394

 
17.7
 %
 
32,304

 
17.8
 %
 
105,907

 
19.1
 %
 
102,473

 
18.7
 %
Selling, General and Administrative Expenses
 
23,050

 
12.2
 %
 
20,351

 
11.2
 %
 
65,005

 
11.7
 %
 
65,175

 
11.9
 %
Operating Income
 
10,344

 
5.5
 %
 
11,953

 
6.6
 %
 
40,902

 
7.4
 %
 
37,298

 
6.8
 %
Interest Expense
 
(6,975
)
 
(3.7
)%
 
(7,403
)
 
(4.1
)%
 
(21,094
)
 
(3.8
)%
 
(22,668
)
 
(4.1
)%
Other Income
 
1,600

 
0.9
 %
 

 
 %
 
1,600

 
0.3
 %
 

 
 %
Income Before Taxes
 
4,969

 
2.6
 %
 
4,550

 
2.5
 %
 
21,408

 
3.9
 %
 
14,630

 
2.7
 %
Income Tax Expense (Benefit)
 
2,347

 
nm

 
(86
)
 
nm

 
7,685

 
nm

 
783

 
nm

Net Income
 
$
2,622

 
1.4
 %
 
$
4,636

 
2.6
 %
 
$
13,723

 
2.5
 %
 
$
13,847

 
2.5
 %
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effective Tax Expense (Benefit) Rate
 
47.2
%
 
nm

 
(1.9
)%
 
nm

 
35.9
%
 
nm

 
5.4
%
 
nm

Diluted Earnings Per Share
 
$
0.24

 
nm

 
$
0.42

 
nm

 
$
1.23

 
nm

 
$
1.28

 
nm

nm = not meaningful
Net Revenues by End-Use Market and Operating Segment
Net revenues by end-use market and operating segment during the three and nine months of 2014 and 2013, respectively, were as follows:

17

Table of Contents


 
 
Three Months Ended
 
Nine Months Ended
 
 
 
 
(In thousands)
 
% of Net Revenues
 
 
 
(In thousands)
 
% of Net Revenues
 
 
Change
 
September 27, 2014
 
September 28, 2013
 
September 27, 2014
 
September 28,
2013
 
Change
 
September 27, 2014
 
September 28,
2013
 
September 27, 2014
 
September 28,
2013
Consolidated Ducommun
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Military and space
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Defense technologies
 
$
(402
)
 
$
63,552

 
$
63,954

 
34%
 
34%
 
$
(10,992
)
 
$
183,393

 
$
194,385

 
32%
 
36%
Defense structures
 
(2,877
)
 
32,547

 
35,424

 
17%
 
20%
 
(2,674
)
 
97,122

 
99,796

 
18%
 
18%
Commercial aerospace
 
10,644

 
62,455

 
51,811

 
33%
 
29%
 
16,110

 
177,405

 
161,295

 
32%
 
29%
Natural resources
 
1,023

 
10,358

 
9,335

 
6%
 
5%
 
3,536

 
31,924

 
28,388

 
6%
 
5%
Industrial
 
(2,442
)
 
9,609

 
12,051

 
5%
 
7%
 
(2,165
)
 
31,428

 
33,593

 
6%
 
6%
Medical and other
 
930

 
9,643

 
8,713

 
5%
 
5%
 
1,943

 
33,161

 
31,218

 
6%
 
6%
Total
 
$
6,876

 
$
188,164

 
$
181,288

 
100%
 
100%
 
$
5,758

 
$
554,433

 
$
548,675

 
100%
 
100%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DAS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Military and space (defense structures)
 
$
(2,877
)
 
$
32,547

 
$
35,424

 
40%
 
46%
 
$
(2,674
)
 
$
97,122

 
$
99,796

 
40%
 
43%
Commercial aerospace
 
6,494

 
48,810

 
42,316

 
60%
 
54%
 
9,864

 
144,505

 
134,641

 
60%
 
57%
Total
 
$
3,617

 
$
81,357

 
$
77,740

 
100%
 
100%
 
$
7,190

 
$
241,627

 
$
234,437

 
100%
 
100%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DLT
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Military and space (defense technologies)
 
$
(402
)
 
$
63,552

 
$
63,954

 
60%
 
62%
 
$
(10,992
)
 
$
183,393

 
$
194,385

 
58%
 
62%
Commercial aerospace
 
4,150

 
13,645

 
9,495

 
13%
 
9%
 
6,246

 
32,900

 
26,654

 
11%
 
8%
Natural resources
 
1,023

 
10,358

 
9,335

 
9%
 
9%
 
3,536

 
31,924

 
28,388

 
10%
 
9%
Industrial
 
(2,442
)
 
9,609

 
12,051

 
9%
 
12%
 
(2,165
)
 
31,428

 
33,593

 
10%
 
11%
Medical and other
 
930

 
9,643

 
8,713

 
9%
 
8%
 
1,943

 
33,161

 
31,218

 
11%
 
10%
Total
 
$
3,259

 
$
106,807

 
$
103,548

 
100%
 
100%
 
$
(1,432
)
 
$
312,806

 
$
314,238

 
100%
 
100%
Net revenues for the three months ended September 27, 2014 were approximately $188.2 million, compared to approximately $181.3 million for the three months ended September 28, 2013. The net revenue increase year-over-year primarily reflects an approximate 21% increase in revenue in the commercial aerospace end-use markets that was partially offset by an approximate 3% decrease in revenue in the military and space end-use markets.
Net revenues for the nine months ended September 27, 2014 were approximately $554.4 million, compared to approximately $548.7 million for the nine months ended September 28, 2013. The net revenue increase year-over-year primarily reflects an approximate 10% increase in revenue in the commercial aerospace end-use markets and an approximate 4% increase in revenue in the non-aerospace and defense (“non-A&D”) end-use markets, partially offset by an approximate 5% decrease in revenue in the military and space end-use markets.
Net Revenues by Major Customers
A significant portion of our net revenues are to our top ten customers as follows:
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 27, 2014
 
September 28, 2013
 
September 27, 2014
 
September 28, 2013
Boeing
 
21
%
 
19
%
 
20
%
 
18
%
Raytheon
 
9
%
 
10
%
 
9
%
 
10
%
Total top ten customers
 
61
%
 
60
%
 
59
%
 
57
%


18

Table of Contents

Boeing and Raytheon represented the following percentages of total accounts receivable:
 
 
September 27, 2014
 
December 31, 2013
Boeing
 
17
%
 
12
%
Raytheon
 
8
%
 
8
%
The revenues and accounts receivable from Boeing and Raytheon are diversified over a number of commercial, military and space programs and were made by both operating segments.
Gross Profit
Gross profit margin was essentially flat but gross profit dollars increased year-over-year in the three months ended September 27, 2014 compared to the three months ended September 28, 2013 primarily due higher net revenue that was partially offset by higher accrued compensation and benefit costs and additional costs incurred as a result of a major outside supplier’s delay in deliveries.
Gross profit margins and dollars increased year-over-year in the nine months ended September 27, 2014 compared to the nine months ended September 28, 2013 primarily due to a favorable product mix, higher gross profit, and an approximately $0.8 million workers’ compensation audit refund related to prior years, partially offset by an increase in accrued compensation and benefit costs.
Selling, General and Administrative Expenses (“SG&A”)
SG&A expenses increased year-over-year in the three months ended September 27, 2014 compared to the three months ended September 28, 2013 primarily due to higher accrued compensation and benefit costs.
SG&A expenses decreased year over year in the nine months ended September 27, 2014 compared to the nine months ended September 28, 2013 primarily due to lower non-recurring professional fees combined with the prior year included an approximate $0.5 million charge related to the Company’s debt repricing transaction, partially offset by higher accrued compensation and benefit costs.
Interest Expense
Interest expense decreased year over year in the three months ended September 27, 2014 compared to the three months ended September 28, 2013 primarily due to lower outstanding debt balances and interest rate reduction as a result of repricing our term loan towards the end of the first quarter of 2013.
Interest expense decreased year over year in the nine months ended September 27, 2014 compared to the nine months ended September 28, 2013 primarily due to lower outstanding debt balances and interest rate reduction as a result of repricing our term loan towards the end of the first quarter of 2013.
Other Income
Other income for both the three months and nine months ended September 27, 2014 was made up of $1.6 million of insurance recoveries related to property and equipment.
Income Tax Expense
We recorded income tax expense of approximately $2.3 million (effective tax rate of 47.2%) for the three months ended September 27, 2014 compared to an income tax benefit of approximately $0.1 million (effective tax benefit rate of 1.9%) for the three months ended September 28, 2013. The effective tax rate for the three months ended September 27, 2014 did not include a benefit from the federal research and development (“R&D”) tax credit as it expired on December 31, 2013. The three months ended September 28, 2013 included a federal R&D tax credit benefit of approximately $0.7 million. The federal R&D tax credit has not yet been extended for 2014, therefore, there was no federal R&D tax credit benefit recognized in the three months ended September 27, 2014. In addition, the effective tax rate for the three months ended September 27, 2014 included a total of approximately $0.9 million additional tax expense as a result of lowering our Qualified Domestic Production Activities Deduction due to lower taxable income resulting from tax returns filed or to be filed.
We recorded income tax expense of approximately $7.7 million (effective tax rate of 35.9%) for the nine months ended September 27, 2014 compared to approximately $0.8 million (effective tax rate of 5.4%) for the nine months ended September 28, 2013. The effective tax rate for for the nine months ended September 27, 2014 did not include a benefit from the federal R&D tax credit as it expired on December 31, 2013. The nine months ended September 28, 2013 included a federal R&D tax credit benefit of approximately $3.7 million. This amount included approximately $2.0 million of 2012 federal research and development tax credit benefit recognized in the nine months ended September 28, 2013 as a result of the American Taxpayer Relief Act of 2012 (the “Act”) passed in January 2013. The Act included an extension of the federal research and development tax credit for amounts paid or incurred during 2012 and 2013. The

19

Table of Contents

federal R&D tax credit has not yet been extended for 2014, therefore, there was no federal R&D tax credit benefit recognized in the nine months ended September 27, 2014.
Net Income and Earnings per Diluted Share
Net income and earnings per diluted share for the three months ended September 27, 2014 were approximately $2.6 million, or $0.24 per diluted share, compared to approximately $4.6 million, or $0.42 per diluted share, for the three months ended September 28, 2013. Net income for the three months ended September 27, 2014 decreased primarily due to higher income tax expense and higher accrued compensation and benefit costs, partially offset by insurance recoveries related to property and equipment and lower interest expense.

Net income and earnings per diluted share for the nine months ended September 27, 2014 were approximately $13.7 million, or $1.23 per diluted share, compared to approximately $13.8 million, or $1.28 per diluted share, for the nine months ended September 28, 2013. Net income for the first nine months of fiscal 2014 compared to the comparable period of fiscal 2013 included higher income tax expense, partially offset by insurance recoveries related to property and equipment, higher revenue, higher gross profit, and lower interest expense.


20

Table of Contents

Business Segment Performance
We report our financial performance based upon the two reportable operating segments: DAS and DLT. The results of operations differ between our reportable operating segments due to differences in competitors, customers, extent of proprietary deliverables and performance. The following table summarizes our business segment performance for the three and nine months ended September 27, 2014 and September 28, 2013:
 
 
Three Months Ended
 
Nine Months Ended
 
 
%
 
(In thousands)
 
% of Net Revenues
 
%
 
(In thousands)
 
% of Net Revenues
 
 
Change
 
September 27,
2014
 
September 28, 2013
 
September 27,
2014
 
September 28,
2013
 
Change
 
September 27, 2014
 
September 28, 2013
 
September 27, 2014
 
September 28, 2013
Net Revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DAS
 
4.7
%
 
$
81,357

 
$
77,740

 
43.2
 %
 
42.9
 %
 
3.1
 %
 
$
241,627

 
$
234,437

 
43.6
 %
 
42.7
 %
DLT
 
3.1
%
 
106,807

 
103,548

 
56.8
 %
 
57.1
 %
 
(0.5
)%
 
312,806

 
314,238

 
56.4
 %
 
57.3
 %
Total Net Revenues
 
3.8
%
 
$
188,164

 
$
181,288

 
100.0
 %
 
100.0
 %
 
1.0
 %
 
$
554,433

 
$
548,675

 
100.0
 %
 
100.0
 %
Segment Operating Income
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DAS
 
 
 
$
7,190

 
$
7,633

 
8.8
 %
 
9.8
 %
 
 
 
$
27,269

 
$
23,766

 
11.3
 %
 
10.1
 %
DLT
 
 
 
8,288

 
7,596

 
7.8
 %
 
7.3
 %
 
 
 
26,089

 
26,772

 
8.3
 %
 
8.5
 %
 
 
 
 
15,478

 
15,229

 
 
 
 
 
 
 
53,358

 
50,538

 
 
 
 
Corporate General and Administrative Expenses (1)
 
 
 
(5,134
)
 
(3,276
)
 
(2.7
)%
 
(1.8
)%
 
 
 
(12,456
)
 
(13,240
)
 
(2.2
)%
 
(2.4
)%
Total Operating Income
 
 
 
$
10,344

 
$
11,953

 
5.5
 %
 
6.6
 %
 
 
 
$
40,902

 
$
37,298

 
7.4
 %
 
6.8
 %
EBITDA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DAS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating Income
 
 
 
$
7,190

 
$
7,633

 
 
 
 
 
 
 
$
27,269

 
$
23,766

 
 
 
 
Other Income (2)
 
 
 
1,600

 

 
 
 
 
 
 
 
1,600

 

 
 
 
 
Depreciation and Amortization
 
 
 
2,272

 
2,621

 
 
 
 
 
 
 
8,242

 
7,386

 
 
 
 
 
 
 
 
11,062

 
10,254

 
13.6
 %
 
13.2
 %
 
 
 
37,111

 
31,152

 
15.4
 %
 
13.3
 %
DLT
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating Income
 
 
 
8,288

 
7,596

 
 
 
 
 
 
 
26,089

 
26,772

 

 
 
Depreciation and Amortization
 
 
 
4,391

 
4,540

 
 
 
 
 
 
 
13,442

 
13,863

 
 
 
 
 
 
 
 
12,679

 
12,136

 
11.9
 %
 
11.7
 %
 
 
 
39,531

 
40,635

 
12.6
 %
 
12.9
 %
Corporate General and Administrative Expenses (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating Loss
 
 
 
(5,134
)
 
(3,276
)
 
 
 
 
 
 
 
(12,456
)
 
(13,240
)
 
 
 
 
Depreciation and Amortization
 
 
 
41

 
41

 
 
 
 
 
 
 
145

 
126

 
 
 
 
 
 
 
 
(5,093
)
 
(3,235
)
 
 
 
 
 
 
 
(12,311
)
 
(13,114
)
 
 
 
 
EBITDA
 
 
 
$
18,648

 
$
19,155

 
9.9
 %
 
10.6
 %
 
 
 
$
64,331

 
$
58,673

 
11.6
 %
 
10.7
 %

(1)
Includes costs not allocated to either the DLT or DAS operating segments.
(2)
Insurance recoveries related to property and equipment included as other income.
Ducommun AeroStructures
DAS’s net revenues in the three months ended September 27, 2014 compared to the three months ended September 28, 2013 increased approximately 5% primarily due to an approximate 15% increase in commercial aerospace revenue that was partially offset by an approximate 8% decrease in military and space revenue. DAS’s net revenues for the nine months ended September 27, 2014 compared to the nine months ended September 28, 2013 increased approximately 3% primarily due to an approximate 7% increase in commercial aerospace revenue that was partially offset by an approximate 3% decrease in military and space revenue.
The DAS segment operating income decreased in the three month period ending September 27, 2014 as a result of additional costs

21

Table of Contents

incurred as a result of a major outside supplier’s delay in deliveries that was partially offset by higher revenue. The DAS EBITDA increased during the three month period ended September 27, 2014 primarily due to $1.6 million of insurance recoveries related to property and equipment that was recorded as other income and none in the comparable period in 2013.
The DAS segment operating income and EBITDA increased in the nine month period ending September 27, 2014, as a result of a favorable product mix and a $0.8 million workers’ compensation audit refund related to prior years. The DAS EBITDA included $1.6 million of insurance recoveries related to property and equipment that was recorded as other income and none in the comparable period in 2013.
Ducommun LaBarge Technologies
DLT’s net revenues in the three months ended September 27, 2014 compared to the three months ended September 28, 2013 increased approximately 3% primarily due to an approximate 44% increase in commercial aerospace revenue. DLT's net revenues in the nine months ended September 27, 2014 compared to the nine months ended September 28, 2013 was essentially flat primarily due to an approximate 6% decrease in defense technologies revenue, partially offset by an an approximate 23% increase in commercial aerospace revenue and an approximate 4% increase in non-A&D revenue.
DLT’s segment operating income and EBITDA increased in the three month period ending September 27, 2014 compared to the three months ended September 28, 2013 as a result of an increase in revenue, favorable product mix, and improved operations, partially offset by higher accrued compensation and benefit costs. DLT’s segment operating income and EBITDA decreased in the nine month period ending September 27, 2014 compared to the nine months ended September 28, 2013 as result of higher accrued compensation and benefit costs and lower revenue, partially offset by favorable product mix.
Corporate General and Administrative (“CG&A”)
CG&A expenses increased approximately $1.9 million in the three months ending September 27, 2014 compared to the three months ended September 28, 2013 primarily due to higher accrued compensation and benefit costs. CG&A expenses decreased approximately $0.8 million in the nine months ending September 27, 2014 compared to the nine months ended September 28, 2013 primarily due to the the first quarter of 2013 that included an approximate $0.5 million charge related to our debt repricing transaction.
Backlog
Backlog is subject to delivery delays or program cancellations, which are beyond our control. Backlog is affected by timing differences in the placement of customer orders and tends to be concentrated in several programs to a greater extent than our net revenues. Backlog in non-aerospace and defense markets tends to be of a shorter duration and is generally fulfilled within a 3-month period. As a result of these factors, trends in our overall level of backlog may not be indicative of trends in our future net revenues. Approximately $455 million of total backlog is expected to be delivered over the next 12 months. The following table summarizes our backlog as of September 27, 2014 and December 31, 2013:

22

Table of Contents

 
 
(In thousands)
 
 
Change
 
September 27,
2014
 
December 31,
2013
Consolidated Ducommun
 
 
 
 
 
 
Military and space
 
 
 
 
 
 
Defense technologies
 
$
(38,448
)
 
$
179,005

 
$
217,453

Defense structures
 
(24,422
)
 
93,311

 
117,733

Commercial aerospace
 
(5,648
)
 
225,555

 
231,203

Natural resources
 
1,371

 
24,176

 
22,805

Industrial
 
10,094

 
23,710

 
13,616

Medical and other
 
5,737

 
22,920

 
17,183

Total
 
$
(51,316
)
 
$
568,677

 
$
619,993

DAS
 
 
 
 
 
 
Military and space (defense structures)
 
$
(24,422
)
 
$
93,311

 
$
117,733

Commercial aerospace
 
(17,669
)
 
187,861

 
205,530

Total
 
$
(42,091
)
 
$
281,172

 
$
323,263

DLT
 
 
 
 
 
 
Military and space (defense technologies)
 
$
(38,448
)
 
$
179,005

 
$
217,453

Commercial aerospace
 
12,021

 
37,694

 
25,673

Natural resources
 
1,371

 
24,176

 
22,805

Industrial
 
10,094

 
23,710

 
13,616

Medical and other
 
5,737

 
22,920

 
17,183

Total